7 News ·general ·1 hour ago

Migraine prevention drug Emgality put on the Pharmaceutical Benefits Scheme, now hundreds

Thousands of Australians living with severe migraines will now pay a fraction of the cost for a treatment many describe as life changing. From June 1, the migraine prevention drug Emgality has been expanded on the Pharmaceutical Benefits Scheme , making it available to patients experiencing eight or more migraine days each month.

Summary by Glance · 7 News

Newer
Next